State Street
AMPE

State Street’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

State Street’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,053
Closed -$37K – 4996
2022
Q3 		$37K Hold
2,053
– – ﹤0.01% 4724
2022
Q2 		$103K Sell
2,053
-9,383
-82% -$698K ﹤0.01% 4525
2022
Q1 		$1.61M Buy
11,436
+221
+2% +$32.3K ﹤0.01% 3650
2021
Q4 		$1.92M Sell
11,215
-218
-2% -$81.3K ﹤0.01% 3650
2021
Q3 		$5.69M Buy
11,433
+2,109
+23% +$978K ﹤0.01% 3169
2021
Q2 		$4.67M Buy
9,324
+9,137
+4,886% +$4.91M ﹤0.01% 3287
2021
Q1 		$95K Hold
187
– – ﹤0.01% 3907
2020
Q4 		$89K Buy
187
+31
+20% +$10.2K ﹤0.01% 3816
2020
Q3 		$45K Hold
156
– – ﹤0.01% 3763
2020
Q2 		$30K Hold
156
– – ﹤0.01% 3747
2020
Q1 		$19K Hold
156
– – ﹤0.01% 3704
2019
Q4 		$27K Hold
156
– – ﹤0.01% 3756
2019
Q3 		$23K Hold
156
– – ﹤0.01% 3759
2019
Q2 		$18K Sell
156
-3,451
-96% -$547K ﹤0.01% 3779
2019
Q1 		$608K Buy
3,607
+212
+6% +$36.3K ﹤0.01% 3420
2018
Q4 		$402K Sell
3,395
-201
-6% -$30.8K ﹤0.01% 3478
2018
Q3 		$548K Buy
3,596
+792
+28% +$331K ﹤0.01% 3465
2018
Q2 		$1.85M Buy
2,804
+2,634
+1,549% +$1.97M ﹤0.01% 3299
2018
Q1 		$173K Buy
170
+81
+91% +$67.8K ﹤0.01% 3568
2017
Q4 		$109K Hold
89
– – ﹤0.01% 3604
2017
Q3 		$16K Hold
89
– – ﹤0.01% 3731
2017
Q2 		$14K Sell
89
-2,091
-96% -$423K ﹤0.01% 3672
2017
Q1 		$523K Buy
2,180
+2
+0.1% +$538 ﹤0.01% 3376
2016
Q4 		$588K Buy
2,178
+15
+0.7% +$3.57K ﹤0.01% 3374
2016
Q3 		$481K Buy
2,163
+5
+0.2% +$1.4K ﹤0.01% 3294
2016
Q2 		$834K Buy
2,158
+2,034
+1,640% +$2.22M ﹤0.01% 3309
2016
Q1 		$84K Hold
124
– – ﹤0.01% 3570
2015
Q4 		$131K Buy
124
+2
+2% +$1.98K ﹤0.01% 3531
2015
Q3 		$106K Hold
122
– – ﹤0.01% 3529
2015
Q2 		$87K Sell
122
-1,711
-93% -$1.82M ﹤0.01% 3550
2015
Q1 		$4.14M Buy
1,833
+163
+10% +$278K ﹤0.01% 2667
2014
Q4 		$1.72M Buy
1,670
+134
+9% +$143K ﹤0.01% 3102
2014
Q3 		$1.63M Buy
1,536
+28
+2% +$47.1K ﹤0.01% 3102
2014
Q2 		$3.78M Buy
1,508
+34
+2% +$69.4K ﹤0.01% 2740
2014
Q1 		$2.81M Buy
1,474
+137
+10% +$324K ﹤0.01% 2892
2013
Q4 		$2.86M Buy
1,337
+255
+24% +$603K ﹤0.01% 2902
2013
Q3 		$2.44M Buy
1,082
+27
+3% +$52.2K ﹤0.01% 2937
2013
Q2 		$1.82M Buy
+1,055
New +$1.67M ﹤0.01% 3027

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

State Street's AMPE Position: Q4 2022 in Review

State Street sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 2,053 shares — an estimated $37K sold.

State Street first reported a position in AMPE in Q2 2013 and held it in 38 quarters. The position peaked at $5.69M in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • State Street reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • State Street sold 2,053 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $37K.
  • State Street first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 38 quarters.
  • State Street's Ampio Pharmaceuticals Inc. position peaked at $5.69M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.